surely GSKs liability is significantthe promotion of Relenza vs tamiflu worldwide seems like chalk and cheesesurely GSK is reponsible for a much greater liability than the 400 mil !the fools at GSK had no idea of the goldmine they were on
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint